Antibody blockade of Jagged1 attenuates choroidal neovascularization.
Saved in:
| Title: | Antibody blockade of Jagged1 attenuates choroidal neovascularization. |
|---|---|
| Authors: | Gjølberg TT; Department of Immunology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, 0372, Oslo, Norway.; Center of Eye Research, Department of Ophthalmology, Oslo University Hospital and University of Oslo, 0450, Oslo, Norway., Wik JA; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway.; Department of Nutrition, Division of Molecular Nutrition, Institute of Basic Medical Sciences, University of Oslo, 0372, Oslo, Norway., Johannessen H; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway.; Department of Pediatric Surgery, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway., Krüger S; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway., Bassi N; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway., Christopoulos PF; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway., Bern M; Department of Immunology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, 0372, Oslo, Norway., Foss S; Department of Immunology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, 0372, Oslo, Norway., Petrovski G; Center of Eye Research, Department of Ophthalmology, Oslo University Hospital and University of Oslo, 0450, Oslo, Norway., Moe MC; Center of Eye Research, Department of Ophthalmology, Oslo University Hospital and University of Oslo, 0450, Oslo, Norway., Haraldsen G; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway., Fosse JH; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway., Skålhegg BS; Department of Nutrition, Division of Molecular Nutrition, Institute of Basic Medical Sciences, University of Oslo, 0372, Oslo, Norway., Andersen JT; Department of Immunology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway. j.t.andersen@medisin.uio.no.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, 0372, Oslo, Norway. j.t.andersen@medisin.uio.no., Sundlisæter E; Department of Pathology, Oslo University Hospital Rikshospitalet, 0372, Oslo, Norway. eiriksundlisater@gmail.com. |
| Source: | Nature communications [Nat Commun] 2023 May 30; Vol. 14 (1), pp. 3109. Date of Electronic Publication: 2023 May 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
